Belpointe Asset Management »

Calidi Biotherapeutics shares owned by Belpointe Asset Management

Quarter-by-quarter ownership of Calidi Biotherapeutics shares owned by Belpointe Asset Management from 13F filings

Historical chart of Belpointe Asset Management investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Belpointe Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Belpointe Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 21k 1.52

More positions owned by Belpointe Asset Management

Servicenow (NOW)
NVIDIA Corporation (NVDA)
Invesco QQQ Trust Etf (QQQ)
Spdr S&p 500 Etf Etf (SPY)
Apple (AAPL)
Schwab Strategic Tr Etf (SCHG)
Collaborative Investmnt Ser Etf (NDOW)
Microsoft Corporation (MSFT)
Ishares Tr Etf (SGOV)
Schwab Strategic Tr Etf (SCHX)
Sch Fnd Us Lg Etf schwb fdt us lg (FNDX)
Vanguard S&P 500 ETF Etf (VOO)
Badger Meter (BMI)
Vanguard Index Fds Etf (VUG)
Amazon (AMZN)

View all positions for Belpointe Asset Management

Top funds holding Calidi Biotherapeutics

HighTower Advisors
Vanguard Group
Geode Capital Management
Belpointe Asset Management
Warberg Asset Management
Rs Crum
UBS Group
Highbridge Capital Management
Finepoint Capital
Apollo Management Holdings
Royal Bank of Canada
Barrett & Company
Advisor Group Holdings
FMR
Tradewinds Capital Management

View all funds holding Calidi Biotherapeutics